Sun Pharma agrees to lower US drug prices under Trump plan; analysts see limited financial impactSun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affor...
02 Sep, 2026, 09.02 AM IST
Permira to buy 25.71% in Cloudnine Hospitals parent: CCI filingPermira, a leading global private equity firm, is ready to buy a significant stake in Cloudnine Hospitals, which places the parent company'...
02 Sep, 2026, 12.00 AM IST
Sun Pharma to extend MFN pricing to US state Medicaid programmesSun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Rec...
01 Sep, 2026, 10.26 AM IST
Yatharth Hospitals draws interest from Aster, Advent as healthcare consolidation heats upAster DM Quality Care is negotiating to acquire a controlling stake in Yatharth Hospitals. This potential acquisition aims to consolidate t...
28 Aug, 2026, 05.30 AM IST
US envoy Sergio Gor meets Piramal Group Chairman Ajay Piramal, discusses expansion plans in USUS Ambassador Sergio Gor met Piramal Group Chairman Ajay Piramal discussing economic ties. Gor lauded Piramal's growing United States footp...
27 Aug, 2026, 01.48 PM IST
Indian companies step up acquisitions for AI, technology and talent: CrisilThe ratings agency said mergers and acquisitions are evolving from an occasional growth option into a core strategic tool for companies see...
26 Aug, 2026, 03.19 PM IST
Entero Healthcare shares gain 15% in 2 days after Prashant Jain’s 3P Investment picks stake in block dealEntero Healthcare Solutions shares rose sharply after Prashant Jain-owned 3P Investment Managers acquired a 2.5% stake in the company throu...
25 Aug, 2026, 10.40 AM IST
Before Xi Jinping's likely India visit, Chinese money is pouring inIndia is cautiously reopening economic channels with China as Chinese linked investment returns after years of restrictions following the G...
24 Aug, 2026, 03.26 PM IST
Horizon Industrial Parks IPO Day 3: Subscription hits 1.45x. Check GMP and other key detailsHorizon Industrial Parks IPO GMP Today: Horizon Industrial Parks IPO enters its final bidding day with 24% subscription after Day 2 and a m...
19 Aug, 2026, 05.09 PM IST
Horizon Industrial Parks IPO Day 2: GMP, subscription status and key details; should you subscribe?Horizon Industrial Parks IPO entered its second day of bidding with a 14% subscription on Day 1. Backed by Blackstone, the Rs 2,600 crore i...
18 Aug, 2026, 08.44 AM IST
Gland Pharma appoints Dr Reddy’s senior executive Deepak Sapra as CEOGland Pharma has appointed Deepak Sapra as its new chief executive officer, with his tenure set to begin on November 16, 2026, subject to h...
14 Aug, 2026, 09.06 AM IST
Warburg set to buy Seacod-maker Universal NutriScience for Rs 2800 croreWill be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.
10 Aug, 2026, 05.30 AM IST
Govt plans new drugs law to overhaul pharma, medical device regulationThe government is set to replace the 1940 Drugs and Cosmetics Act with a new law covering drugs, medical devices and cosmetics. The draft b...
07 Aug, 2026, 06.00 AM IST
India Inc goes on a global shopping spree with a new wishlistIndian companies are increasingly pursuing strategic overseas acquisitions. They now focus on acquiring capabilities and technology rather ...
05 Aug, 2026, 01.47 PM IST
ITC's Sanjiv Puri says CPP acquisition marks 'defining milestone' for paper businessIn a social media post, Puri welcomed the CPP workforce to ITC, saying the integration brings together two enterprises with a shared commit...
03 Aug, 2026, 07.21 PM IST
As we look to the next decade, I hope in the future we can further grow in generics as we transition into drug innovation: Aman Mehta, MD, Torrent PharmaceuticalsTorrent Pharma aims to become a top three Indian drug maker. The company is transitioning from generics to drug innovation for growth. Aman...
31 Jul, 2026, 12.49 AM IST
ChrysCapital acquires controlling 70.68% stake in Novartis India listed unit in first majority pharma investmentChrysCapital has acquired a controlling interest in Novartis India Limited, representing its inaugural investment in India's pharmaceutical...
30 Jul, 2026, 05.16 PM IST